Addiction News and Research

RSS

Drug being used to improve cognition affects dopamine, suggesting potential for abuse

Preliminary research in healthy men suggests that the narcolepsy drug modafinil, increasingly being used to enhance cognitive abilities, affects the activity of dopamine in the brain in a way that may create the potential for abuse and dependence, according to a study in the March 18 issue of JAMA.

17 Mar 2009

Discovery of new mechanism for the processing of endocannabinoids

New research funded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, has identified a new mechanism for the processing of endocannabinoids, natural brain compounds similar to THC, the active ingredient in marijuana.

17 Mar 2009

Close relationships can perpetuate health-compromising behaviors

Human problems rarely occur in a vacuum, but persist as part of ongoing social interaction in which causes and effects are interwoven.

11 Mar 2009

Salt could be 'nature's antidepressant' according to new research

Most people consume far too much salt, and a University of Iowa researcher has discovered one potential reason we crave it: it might put us in a better mood.

11 Mar 2009

Combination of genes and prenatal exposure to smoking increases teens' risk of disruptive behavior

A study funded by the National Institute on Drug Abuse, a component of the National Institutes of Health, shows that prenatal exposure to smoking combined with a specific genetic variant places children at greatest risk for behavioral problems.

5 Mar 2009

Opioid antagonists help pain management

Achieving effective, durable, and safe pain relief, especially in patients with chronic and/or severe pain conditions, can be difficult.

3 Mar 2009

Recent drug use masks cocaine abusers' cognitive impairment

Recent cocaine use may hide some of the cognitive deficits commonly experienced by individuals addicted to cocaine, scientists at the U.S. Department of Energy's Brookhaven National Laboratory report in a study published in the April 2009 issue of Neuropsychopharmacology - a special issue dedicated to cocaine research.

3 Mar 2009

Researchers discover gene variation linked to cocaine addiction and cocaine-induced paranoia

Researchers from Boston University School of Medicine (BUSM) and Yale University School of Medicine and the University of Connecticut School of Medicine, have discovered that variants in the á-endomannosidase (MANEA) gene are associated with cocaine addiction and cocaine-induced paranoia in European American and African American populations.

2 Mar 2009

New insights into addiction

A new comprehensive review by researchers at the Montreal Neurological Institute (MNI), McGill University and the University of Cambridge, England provides vital insights into the neurological basis of addiction by investigating Parkinson's disease patients, who in some instances develop various addictions when undergoing medical treatment.

25 Feb 2009

Treating drug-addicted doctors is good medicine

Doctors who become addicted to alcohol and other drugs can be treated successfully and returned to medical practice with the help of special programs that couple referral to treatment and monitoring with rapid responses to noncompliance, University of Florida researchers report.

24 Feb 2009

Internet addiction linked to aggression in teenagers

Armed with the findings of a new study, Taiwanese researchers suggest parents and educators pay more attention to children's online habits because Internet-addicted teens seem more prone to aggression.

23 Feb 2009

Taurine: Key to the visual toxicity of an anti-epileptic drug for children?

Vigabatrin (Sabril), first intention molecule for the treatment of epilepsy in children, in many cases produces secondary effects that lead to an irreversible loss of vision.

18 Feb 2009

Ondansetron shown to be a viable treatment option for opioid addiction

Scientists at Stanford University School of Medicine have discovered that a commonly available non-addictive drug can prevent symptoms of withdrawal from opioids with little likelihood of serious side effects.

18 Feb 2009

Medical prescription of heroin does not pose neighborhood risk

Providing heroin to drug addicts at medically supervised clinics does not pose risks to surrounding neighbourhoods, according to a new study by Serge Brochu, a researcher at the Université de Montréal School of Criminology.

18 Feb 2009

Experts predict 20 per cent drop in lung cancer rate

Cancer Reserach UK experts are predicting that lung cancer rates will drop by nearly a fifth over the next 20 years, according to new figures.

18 Feb 2009

Mouse study reveals genetic component of empathy

The ability to empathize with others is partially determined by genes, according to new research on mice from the University of Wisconsin-Madison and Oregon Health and Science University (OHSU).

15 Feb 2009

New guidelines for prescribing opioid pain drugs

A prestigious panel of pain-management experts representing the American Pain Society (APS) www.ampainsoc.org and the American Academy of Pain Medicine (AAPM) has published the first comprehensive clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.

10 Feb 2009

More evidence showing exercise helps people give up smoking

Research from the University of Exeter reveals for the first time, that changes in brain activity, triggered by physical exercise, may help reduce cigarette cravings.

10 Feb 2009

New guideline for prescribing opioid pain drugs published

A national panel of pain management experts representing the American Pain Society (APS) and the American Academy of Pain Medicine (AAPM) has published the first comprehensive, evidence-based clinical practice guideline to assist clinicians in prescribing potent opioid pain medications for patients with chronic non-cancer pain.

8 Feb 2009

Calcitrol - active form of vitamin D - stimulates protein that inhibits growth of breast cancer cells

Calcitrol, the active form of vitamin D, has been found to induce a tumor suppressing protein that can inhibit the growth of breast cancer cells, according to a study by researcher Sylvia Chistakos, Ph.D., of the UMDNJ-New Jersey Medical School.

5 Feb 2009